# The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients

> **NCT00437918** · PHASE4 · COMPLETED · sponsor: **Inje University** · enrollment: 85 (actual)

## Conditions studied

- Diabetes Mellitus
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** nateglinide
- **DRUG:** acarbose

## Key facts

- **NCT ID:** NCT00437918
- **Lead sponsor:** Inje University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2008-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437918, "The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00437918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*